Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2007
03/07/2007EP1758585A2 Hiv integrase inhibitors
03/07/2007EP1758584A1 Methods for treating a mammal before, during and after cardiac arrest
03/07/2007EP1758583A2 Arylpiperazine derivatives useful as adrenergic receptor antagonists
03/07/2007EP1758582A1 Amido compounds and their use as pharmaceuticals
03/07/2007EP1758581A1 Combinations comprising a 4-isoquinolone derivative and anti-hiv agents
03/07/2007EP1758580A2 N-substituted piperidines and their use as pharmaceuticals
03/07/2007EP1758579A1 Crth2 receptor ligands for medicinal uses
03/07/2007EP1758578A2 Novel indazole carboxamides and their use
03/07/2007EP1758577A2 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
03/07/2007EP1758576A1 Topical and intravaginal microbicidal and antiparasitic compositions comprising quassinoids or quassionid-containing plant extracts
03/07/2007EP1758575A1 Counteracting drug-induced obesity using glp-1 agonists
03/07/2007EP1758574A1 Pharmaceutical compositions containing polyunsaturated fatty acid and at least one of an immunosuppressive agent or an antineoplastic agent
03/07/2007EP1758573A1 A pharmaceutical composition and its use
03/07/2007EP1758572A1 Combinations of hyaluronic acid and polyunsaturated fatty acids
03/07/2007EP1758571A1 Crth2 receptor ligands for therapeutic use
03/07/2007EP1758570A1 Composition for treatment of a hydrofluoric acid burn
03/07/2007EP1758568A1 System and method for transdermal delivery of an anticoagulant
03/07/2007EP1758567A1 Partially-fluorinated ethers, compositions and uses thereof, for long-term tamponade in the eye
03/07/2007EP1758566A2 Use of cb2 receptors agonists for the treatment of huntington"s disease
03/07/2007EP1758565A2 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
03/07/2007EP1758564A2 Synergistic methods and compositions for treating cancer
03/07/2007EP1758563A1 Combination therapy with glatiramer acetate and minocycline for the treatment of multiple sclerosis
03/07/2007EP1758562A2 Compositions and methods for bone formation and remodeling
03/07/2007EP1758560A1 Hormonal contraceptive containing a combination of ethinyl estradiol and chlormadinone acetate
03/07/2007EP1758557A2 Swellable dosage form comprising gellan gum
03/07/2007EP1758552A1 Intraocular implants of alpha-2 adrenergic receptor agonists and methods for improving vision
03/07/2007EP1758470A1 Prebiotic preparation
03/07/2007EP1758469A2 Improvement of barrier integrarity in hiv patients by use of fatty acids
03/07/2007EP1758458A2 Compositions containing opioid antagonists
03/07/2007EP1758453A2 C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
03/07/2007EP1758452A1 Synthesis of metabolically stable analgesics, pain medications and other agents
03/07/2007EP1704149B1 Triaza-cyclopenta[cd]indene derivatives
03/07/2007EP1696902A4 Compositions containing d-tocopherol compound polybasic acid partial esters
03/07/2007EP1689731B1 2-phenyl-benzofuran derivatives, method for the production thereof and their use
03/07/2007EP1685131B1 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
03/07/2007EP1663160B1 Melt-formulated, multi-particulate oral dosage form
03/07/2007EP1628673B1 Pharmaceutical compositions comprising an extract of euphorbia prostrata
03/07/2007EP1562615A4 Oral and dental composition
03/07/2007EP1542680B1 1, 4, 5-substituted 1, 2-dihydro-pyrazol-3-one and 3-alkoxy-1h-pyrazole derivatives as tnf-alpha and interleukin lowering agents for the treatment of inflammations
03/07/2007EP1531842A4 Regulation of cell growth by muc1
03/07/2007EP1513842B1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines
03/07/2007EP1478355B1 Antitumor compositions containing taxane derivatives
03/07/2007EP1462101B1 Drinkable preparation comprising ketoprofen and use thereof in the simultaneous treatment of a group of animals of respiratory diseases
03/07/2007EP1461342B1 Streptogramin derivatives, preparation thereof and compositions containing same
03/07/2007EP1450780B1 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation
03/07/2007EP1442025B1 Pyrimidinones as melanin concentrating hormone receptor 1
03/07/2007EP1440066B1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
03/07/2007EP1430152B1 Gene and protein relating to hepatocellular carcinoma
03/07/2007EP1427728B1 6,7-DIHYDRO-5H-PYRAZOLO 1,2-A PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY cYTOKINES
03/07/2007EP1427411B1 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo [3.1.0] hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
03/07/2007EP1414315B1 Complex antioxidant preparation
03/07/2007EP1406591B1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone
03/07/2007EP1381370B1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
03/07/2007EP1372651B1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
03/07/2007EP1368304B1 Prodrugs of excitatory amino acids
03/07/2007EP1362052B1 Inhibitors of cruzipain and other cysteine proteases
03/07/2007EP1352061B9 Method for inhibiting the expression of a target gene
03/07/2007EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof
03/07/2007EP1327149A4 Methods of high-throughput screening for internalizing antibodies
03/07/2007EP1317408B1 Method for the purification of lactic acid on an industrial scale
03/07/2007EP1313449B1 Amphotericin b structured emulsion
03/07/2007EP1303519B1 Tricyclic imidazopyridines
03/07/2007EP1267885B1 Male contraceptive formulation comprising norethisterone and testosterone undecanoate
03/07/2007EP1255544B1 Mucin synthesis inhibitors
03/07/2007EP1228202B1 Antisense compositions and cancer-treatment methods
03/07/2007EP1223808B1 Peripheral cannabinoid receptor (cb2) selective ligands
03/07/2007EP1220678B1 Pharmaceutical compositions containing copper, salicylic acid and vitamin c
03/07/2007EP1187811B1 Inhibitors of metalloproteinases
03/07/2007EP1105098B1 Liposomal therapeutic compositions obtainable through the use of an ammonium sulphate gradient
03/07/2007EP1061922B9 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
03/07/2007EP1043998B1 USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDANT KINASE INHIBITORS
03/07/2007EP1032387B1 Novel metal complexes
03/07/2007EP1009752B1 Novel molecules of the tango-77 related protein family and uses thereof
03/07/2007EP1001970B1 Dipeptide derivatives as growth hormone secretagogues
03/07/2007EP0996444B1 Treatment of diabetes with thiazolidinedione and metformin
03/07/2007EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics
03/07/2007EP0927062B1 Skin battery cosmetic composition
03/07/2007EP0831797B1 Pharmaceutically active carotenoids
03/07/2007EP0585242B2 Wound healing
03/07/2007CN1926155A 羟乙基淀粉 Hydroxyethyl starch
03/07/2007CN1926154A EC SOD and cell transducing EC SOD and use thereof
03/07/2007CN1926148A Beta-aminoacid-derivatives as factor Xa inhibitors
03/07/2007CN1926143A Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases
03/07/2007CN1926140A Pyrrolopyrimidine derivatives
03/07/2007CN1926137A Pyrrole-derivatives as factor Xa inhibitors
03/07/2007CN1926136A Amino cyclopropane carboxamide derivatives as bradykinin antagonists
03/07/2007CN1926135A Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
03/07/2007CN1926133A Epothilone derivatives
03/07/2007CN1926132A Pyrazole compounds useful as protein kinase inhibitors
03/07/2007CN1926130A Bis-indole pyrroles useful as antimicrobials agents
03/07/2007CN1926128A Dipeptidyl peptidase inhibitors
03/07/2007CN1926127A Novel 2-heteroaryl-substituted benzimidazole derivative
03/07/2007CN1926122A Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
03/07/2007CN1926121A Thiazole derivatives and use thereof
03/07/2007CN1926119A Sulphonamide substituted triazines as chemokine receptor modulators
03/07/2007CN1926118A Dimeric small molecule potentiators of apoptosis
03/07/2007CN1926117A 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power
03/07/2007CN1926115A Novel therapeutic agent for amyotrophic lateral sclerosis(ALS) or disease attributable to ALS
03/07/2007CN1926114A Processes for preparing substituted N-aryl-N'-[3-(1H-pyrazol-5-yl) phenyl] ureas and intermediates thereof
03/07/2007CN1926113A Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
1 ... 3850 3851 3852 3853 3854 3855 3856 3857 3858 3859 3860 3861 3862 3863 3864 3865 3866 3867 3868 3869 3870 ... 7860